US lawmaker and watchdog probe plans to weaken conflict-of-interest rules
This article was originally published in SRA
Executive Summary
US senator Charles Grassley (Republican-Iowa) has urged the government to halt any plans it might have to dilute a long-awaited Health and Human Services transparency rule aimed at ensuring public disclosure of financial ties between federally funded medical researchers and the pharmaceutical industry1.